Mushtaq, Shazad, Warner, Marina, Johnson, Alan P and Livermore, David M ORCID: https://orcid.org/0000-0002-9856-3703
(2004)
Activity of dalbavancin against staphylococci and streptococci, assessed by BSAC and NCCLS agar dilution methods.
Journal of Antimicrobial Chemotherapy, 54 (3).
pp. 617-20.
ISSN 0305-7453
Abstract
Dalbavancin is a long-half-life (9-12 days) glycopeptide, now in Phase 3 development. Its pharmacokinetics may facilitate home intravenous therapy, early discharge and long prophylaxis.
Item Type: | Article |
---|---|
Uncontrolled Keywords: | anti-bacterial agents,culture media,drug resistance, multiple, bacterial,glycopeptides,microbial sensitivity tests,staphylococcus,streptococcus,teicoplanin |
Faculty \ School: | Faculty of Medicine and Health Sciences > Norwich Medical School |
UEA Research Groups: | Faculty of Medicine and Health Sciences > Research Groups > Epidemiology and Public Health Faculty of Medicine and Health Sciences > Research Groups > Public Health and Health Services Research (former - to 2023) |
Depositing User: | Pure Connector |
Date Deposited: | 06 Jan 2014 15:04 |
Last Modified: | 24 Oct 2022 05:47 |
URI: | https://ueaeprints.uea.ac.uk/id/eprint/46736 |
DOI: | 10.1093/jac/dkh401 |
Actions (login required)
![]() |
View Item |